Skip to main content
SpringerLink
Log in

5-Hydroxyindoleacetic acid (5 HIAA) and homovanillic acid (HVA) following probenecid in acute psychotic patients treated with phenothiazines

  • Original Investigations
  • Human Pharmacology
  • Published:
Psychopharmacologia Aims and scope Submit manuscript

Abstract

Lumbar CSF 5 HIAA and HVA were measured following probenecid administration in acute psychotic patients before and during treatment with phenothiazines. Patients with more classical schizophrenic symptoms had higher values for 5 HIAA/HVA than other psychotics, depressives, and inmate volunteers. Prior to treatment CSF 5 HIAA, but not HVA, correlated significantly with several clinical items related to psychotic disorganization. Phenothiazine treatment produced significant increases in CSF HVA which could not be correlated with the dose of antipsychotic or antiparkinson drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Aghajanian, G. K.: Influence of drugs on the firing of serotonin-containing neurons in brain. Fed. Proc. 31, 91–96 (1972).

    Google Scholar 

  • Anden, N.-E., Roos, B.-E., Werdinius, B.: Effects of chlorpromazine, haloperidol, and reserpine on the levels of phenolic acids in rabbit corpus striatum. Life Sci. 3, 149–158 (1964).

    Google Scholar 

  • Bowers, M. B., Jr.: Clinical measurements of central dopamine and 5-hydroxytryptamine metabolism: reliability and interpretation of CSF acid monoamine metabolite measures. Neuropharmacol. 23, 26–33 (1972a).

    Google Scholar 

  • Bowers, M. B., Jr.: CSF 5-HIAA and HVA following probenecid in unipolar depressives treated with amitriptyline. Psychopharmacologia (Berl.) 23, 26–33 (1972b).

    Google Scholar 

  • Bowers, M. B., Jr.: Acute Psychosis induced by psychotomimetic drug abuse II. Neurochemical Findings. Arch. gen. Psychiat. 27, 440–442 (1972).

    Google Scholar 

  • Bowers, M. B., Jr., Heninger, G. R., Gerbode, F. A.: CSF 5-HIAA and HVA in psychiatric patients. Int. J. Neuropharmacol.. 8, 255–262 (1969).

    Google Scholar 

  • Bowers, M. B., Jr., Roth, R. H.: Interaction of atropine-like drugs with dopaminecontaining neurons in rat brain. Brit. J. Pharmacol. 44, 301–306 (1972).

    Google Scholar 

  • Bruno, A., Allegranza, A.: The effect of haloperidol on the urinary excretion of dopamine, homovanillic, and vanilmandelic acids in schizophrenics. Psychopharmacologia (Berl.) 8, 60–66 (1965).

    Google Scholar 

  • Chase, T. N., Schnur, J. A., Gordon, E. K.: CSF monoamine catabolites in drug-induced extrapyramidal disorders. Neuropharmacol. 9, 265–268 (1970).

    Google Scholar 

  • Gerbode, F. A., Bowers, M. B., Jr.: Measurement of acid monoamine metabolites in human and animal CSF. J. Neurochem. 15, 1053–1055 (1968).

    Google Scholar 

  • Korf, J., Van Praag, H. M.: Amine metabolism in the human brain: further evaluation of the probenecid test. Brain Res. 35, 221–230 (1971).

    Google Scholar 

  • Kupfer, D. J., Detre, T. P., Foster, F. G., Tucker, G. J., Delgado, J.: The application of Delgado's telemetric mobility recorder for human studies. Behav. Biol. 7, 585–590 (1972).

    Google Scholar 

  • Mellor, C. S.: The first rank symptoms of schizophrenia. Brit. J. Psychiat. 117, 15–23 (1970).

    Google Scholar 

  • Moir, A. T. B., Ashcroft, G. W., Crawford, T. B. B., Eccleston, D., Guldberg, H. C.: Cerebral metabolites in CSF as a biochemical approach to the brain. Brain 93, 357–368 (1970).

    Google Scholar 

  • O'Keefe, R., Sharman, D. F., Vogt, M.: Effect of drugs used in psychoses on cerebral dopamine metabolism. Brit. J. Pharmacol. 38, 287–304 (1970).

    Google Scholar 

  • Persson, T., Roos, B.-E.: Acid metabolites from monoamines in CSF of chronic schizophrenics. Brit. J. Psychiat. 115, 95–98 (1969).

    Google Scholar 

  • Rimon, R., Roos, R.-E., Rakkolainen, V., Alanen, Y.: The content of 5-HIAA and HVA in the CSF of patients with acute schizophrenia. J. Psychosom. Res. 15, 375–378 (1971).

    Google Scholar 

  • Robins, E., Guze, S. B.: Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Amer. J. Psychiat. 126, 983–987 (1970).

    Google Scholar 

  • Stephens, J. H., Astrup, C., Mangrum, J. C.: Prognostic factors in recovered and deteriorated schizophrenics. Amer. J. Psychiat. 122, 1116–1120 (1966).

    Google Scholar 

  • Tamarkin, N. R., Goodwin, F. K., Axelrod, J.: Rapid elevation of biogenic amine metabolites in human CSF following probenecid. Life Sci. 9, 1397–1408 (1970).

    Google Scholar 

  • Taylor, M. A.: Schneiderian first rank symptoms and clinical prognostic features in schizophrenia. Arch. gen. Psychiat. 26, 64–67 (1972).

    Google Scholar 

  • Van Praag, H. M., Korf, J.: Retarded depression and the dopamine metabolism. Psychopharmacologia (Berl.) 19, 199–203 (1971).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, Yale University, USA

    Malcolm B. Bowers Jr.

  2. The Connecticut Mental Health Center, New Haven, Connecticut, USA

    Malcolm B. Bowers Jr.

Authors
  1. Malcolm B. Bowers Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bowers, M.B. 5-Hydroxyindoleacetic acid (5 HIAA) and homovanillic acid (HVA) following probenecid in acute psychotic patients treated with phenothiazines. Psychopharmacologia 28, 309–318 (1973). https://doi.org/10.1007/BF00422751

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00422751

Key words

Search

Navigation